共 32 条
- [21] Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA (vol 44, pg 1588, 2017)EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) : 2150 - 2151Bozkurt, Murat FaniVirgolini, IreneBalogova, SonaBeheshti, MohsenRubello, DomenicoDecristoforo, ClemensAmbrosini, ValentinaKjaer, AndreasDelgado-Bolton, RobertoKunikowska, JolantaOyen, Wim J. G.Chiti, ArturoGiammarile, FrancescoSundin, AndersFanti, Stefano
- [22] Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPAEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1588 - 1601Murat Fani BozkurtIrene VirgoliniSona BalogovaMohsen BeheshtiDomenico RubelloClemens DecristoforoValentina AmbrosiniAndreas KjaerRoberto Delgado-BoltonJolanta KunikowskaWim J. G. OyenArturo ChitiFrancesco GiammarileStefano Fanti
- [23] Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPAEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 2150 - 2151Murat Fani BozkurtIrene VirgoliniSona BalogovaMohsen BeheshtiDomenico RubelloClemens DecristoforoValentina AmbrosiniAndreas KjaerRoberto Delgado-BoltonJolanta KunikowskaWim J. G. OyenArturo ChitiFrancesco GiammarileAnders SundinStefano Fanti
- [24] 68Ga-DOTA-TOC PET/CT predicts exact tumor staging in head and neck paragangliomas, compared to 18F-DOPA PET/CT and 123I-MIBG SPECT/CTEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S686 - S686Kroiss, A. S.Uprimny, C.Gruber, L.Shulkin, B. L.Virgolini, I. J.
- [25] Prognostic value of interim [68Ga]Ga-DOTA-TOC PET/CT in patients with neuroendocrine tumour who underwent peptide receptor radionuclide therapyEUROPEAN RADIOLOGY, 2024, : 2559 - 2568Shin, EonwooKim, Yong-ilYoo, ChanghoonShin, YeokyeongRyoo, Baek-YeolLee, Dong YunRyu, Jin-Sook
- [26] 68Ga-DOTATATE PET/CT for the early prediction of response to peptide receptor radionuclide therapy in patients with well differentiated neuroendocrine tumoursJOURNAL OF NUCLEAR MEDICINE, 2010, 51Haug, AlexanderAuernhammer, ChristophWaengler, BjoernSchmidt, GerwinCumming, PaulBartenstein, PeterHacker, Marcus
- [27] 68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine TumorsJOURNAL OF NUCLEAR MEDICINE, 2010, 51 (09) : 1349 - 1360Haug, Alexander R.Auernhammer, Christoph J.Waengler, BjoernSchmidt, Gerwin P.Uebleis, ChristopherGoeke, BurkhardCumming, PaulBartenstein, PeterTiling, ReinholdHacker, Marcus
- [28] Head-to-head comparison between 18F-DOPA PET/CT and 68Ga-DOTA-peptide PET/CT in detecting intestinal neuroendocrine tumours: A systematic review and meta-analysisCLINICAL ENDOCRINOLOGY, 2021, 95 (04) : 595 - 605Piccardo, ArnoldoFiz, FrancescoBottoni, GianlucaUgolini, MartinaNoordzij, WalterTrimboli, Pierpaolo
- [29] Molecular Imaging Tumor Volume of Somatostatin Receptor (MITVSSR) on 68Ga-DOTATATE PET/CT, dosimetry and predictors of overall survival and response in unresectable neuroendocrine neoplasms treated with Peptide Receptor Radionuclide Therapy (PRRT)JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 135 - 135Alipour, R.Jackson, P.Callahan, J.Bressel, M.Hogg, A.Hicks, R.Kong, G.
- [30] Somatostatin Receptor Imaging with [18F]FET-βAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative StudyJOURNAL OF NUCLEAR MEDICINE, 2024, 65 (03) : 416 - 422Dubash, SuraiyaBarwick, Tara D.Kozlowski, KasiaRockall, Andrea G.Khan, SairahKhan, SameerYusuf, SirajLamarca, AngelaValle, Juan W.Hubner, Richard A.McNamara, Mairead G.Frilling, AndreaTan, TriciaWernig, FlorianTodd, JeannieMeeran, KarimPratap, BhaveshAzeem, SaleemHuiban, MichaelKeat, NicholasLozano-Kuehne, Jingky P.Aboagye, Eric O.Sharma, Rohini